top of page

Disruptive: Hybrid and Decentralized Clinical Trials

PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina.

LabNews by Corax Consultants LLC. copyright: Corax Consultants LLC

LabNews by Corax Consultants LLC. copyright: Corax Consultants LLC

EmVenio is the largest provider of community-based clinical trial sites served with mobile research units. The acquisition, which is effective immediately, strengthens PCM Trials‘ and EmVenio’s abilities to recruit and retain diverse populations for clinical research studies, as required for regulatory approval.

Site networks are key to delivering critical study data for sponsors; by combining capabilities with EmVenio, PCM Trials now has access to a site network that is focused on serving underrepresented patient populations in previously hard-to-reach communities and can work flexibly with sponsors to achieve their study goals.

Aktuelle Beiträge

Alle ansehen

mRNA-Medikament soll Lipide im Blut senken

Laut einer placebokontrollierten und doppelblinden Studie unter der Leitung von Forschern des Brigham and Women’s Hospital, einem Gründungsmitglied des Mass General Brigham-Gesundheitssystems, könnte

Comments


bottom of page